Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1995
11/02/1995WO1995029186A1 Compositions and methods for cell transformation
11/02/1995WO1995028959A1 MICE MUTANT FOR Fc RECEPTORS AND METHOD OF TREATING AUTOIMMUNE DISEASE
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995WO1995028948A1 Compositions comprising dna damaging agents and p53
11/02/1995WO1995028942A1 Antisense oligomers for inhibiting human papillomaviruses
11/02/1995WO1995028941A1 Composition and method for treatment of cmv infection
11/02/1995WO1995027718A3 Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography
11/02/1995WO1995027060A3 Biologically active eph family ligands
11/02/1995WO1995026410A3 Biological insect control agent
11/02/1995EP0679718A2 Process for producing alpha-interferon
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679716A1 Gene signature
11/02/1995EP0679196A1 Dna sequencing by mass spectrometry
11/02/1995EP0679194A1 Method to predict active growth of bacteria adhered to a surface
11/02/1995EP0679192A1 Improved recombinant production of proteins having factor viii:c activity
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679190A1 Method for generating single-stranded dna molecules
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679188A1 Modified cutinases, dna, vector and host
11/02/1995EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679185A1 Ras associated gap proteins
11/02/1995EP0679184A1 Periplasmic 3':5'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995EP0517833B1 Regeneration and genetic transformation of sugar beet
11/02/1995EP0404967B1 Recombinant c-terminal alpha-amidating enzyme of human thyroid origin
11/02/1995DE4415001A1 Treatment of eukaryotic cells with cpds. that bind lipo-polysaccharide
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188418A1 Genetic sequences conferring disease resistance in plants and uses therefor
11/02/1995CA2188397A1 Human sperm diagnostic
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995CA2188320A1 Compositions and methods for cell transformation
11/02/1995CA2188258A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995CA2188257A1 Dna encoding cephamycin biosynthesis late enzymes
11/02/1995CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995CA2187920A1 Spider neurotoxins and method of producing the same
11/02/1995CA2185673A1 Plant gene specifying acetyl coenzyme a carboxylase and transformed plants containing same
11/02/1995CA2185560A1 Detection of fungal pathogens using the polymerase chain reaction
11/02/1995CA2185550A1 An in vivo gene expression system
10/1995
10/31/1995US5463175 Glyphosate tolerant plants
10/31/1995US5463174 Transformation and foreign gene expression in Brassica species
10/31/1995US5463029 Adsorbing, eluting on cationic exchange resin, followed by same on anionic exchange resin
10/31/1995US5463026 Anti-human prohibitin antibodies
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5463024 Antigen-presenting assembled particle comprising protein molecules of self-assembling, particle-forming polypeptide encoded by gag gene of retrovirus fused to polypeptide defining viral, bacterial or protozoal antigenic epitope
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462873 DNA for use in a simple method for detecting inhibitors of retrotransposition
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995US5462864 Manufacturing method of high purity maltose and its reduced product
10/31/1995US5462862 Antibiotics from microorganisms
10/31/1995US5462856 Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
10/31/1995US5462855 Method for the detection and quantitative determination of nitrosomonas strains in wastewaters or soils
10/31/1995US5462854 Amenable to enzymatic elongation from either, or most preferably both termini under appropriate conditions and in presence of polymerase enzyme
10/31/1995US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core
10/31/1995CA2002516C Process for the expression of a recombinant gene
10/30/1995CA2122874A1 Neural receptor tyrosine kinase
10/28/1995CA2147933A1 Transgenic animals as a model for metabolic bone diseases
10/26/1995WO1995028500A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus
10/26/1995WO1995028496A1 Method for preparing template dna from cell cultures
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system
10/26/1995WO1995028492A1 Dna regulatory elements responsive to cytokines
10/26/1995WO1995028491A1 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby
10/26/1995WO1995028490A1 Expression vector with non-viral promoter
10/26/1995WO1995028489A1 Dihydropyrimidine dehydrogenase compositions and methods of use
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995WO1995028486A2 Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins or vaccinating active principles
10/26/1995WO1995028485A1 Erbb2 promoter binding protein in neoplastic disease
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028482A2 Dna spacer regulatory elements responsive to cytokines and methods for their use
10/26/1995WO1995028481A1 Conserved t-cell receptor sequences
10/26/1995WO1995028478A1 Rps2 gene and uses thereof
10/26/1995WO1995028476A1 Recombinant zymomonas for pentose fermentation
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028423A1 Rps gene family, primers, probes, and detection methods
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028412A1 α(1,3) GALACTOSYLTRANSFERASE NEGATIVE SWINE
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028409A1 Process, apparatus and reagents for isolating cellular components
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
10/26/1995WO1995027047A3 Highly-purified recombinant reverse transcriptase
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188317A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus
10/26/1995CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995CA2188182A1 Conserved t-cell receptor sequences
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy